<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01516034</url>
  </required_header>
  <id_info>
    <org_study_id>CTR-2</org_study_id>
    <nct_id>NCT01516034</nct_id>
  </id_info>
  <brief_title>The Efficacy of the Cupola Ultrasonic Tattoo Removal Device</brief_title>
  <official_title>The Efficacy of the Cupola Ultrasonic Tattoo Removal Device: A Prospective Single Blinded, Before-After Study Design</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cupola Medical Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cupola Medical Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to determine the efficacy of the Cupola tattoo removal device for
      tattoo removal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Cupola system is a non-invasive device for pigment/tattoo removal based on ultrasound
      technology. The safety of the device was demonstrated in a previous pilot study approved by
      the Herzog Helsinki committee #167-09, Ministry of Health April 2010 #HT-5293) showing that
      no risk was associated with the procedure.

      This study is designed to determine the efficacy of the device for tattoo removal in up to 6
      treatments in different treatment intervals. Three areas of the tattoo that are similar in
      size, color, and intensity will be chosen. One area will not be treated; the second will
      receive 6 treatments in 2-3 week intervals; the third will receive 3 treatments in 4-6 week
      intervals. The evaluations will include color measurements, photography, subject comfort and
      skin condition.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sponsor decided that the results were not significant enough to continue.
  </why_stopped>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tattoo Removal Efficiency</measure>
    <time_frame>6 months (termination)</time_frame>
    <description>Extent of Tattoo removal is quantified in 2 methods based on photographs taken at the baseline visit and at the termination visit:
Scoring by independent dermatologist
Measuring pigment clearance using image analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerability Score</measure>
    <time_frame>0, 2, 4, 6, 8, 10 weeks (after every treatment)</time_frame>
    <description>The tolerability of the procedure will be scored by the subject using a Pain Visual Analog Scale on a 0 to 10 scale where 10 represents the highest degree of pain and 0 represents a complete lack of pain.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Tattooing</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cupola Tattoo Removal Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cupola Tattoo Removal device</intervention_name>
    <description>Up to 6 treatments with the device every 2-3 weeks to the tattoo area.</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Tattoos

               -  Age of tattoo - more than 1 year since application

               -  Type - decorative (not cosmetic)

               -  Not previously treated

          2. General

               -  At least 18 years of age

               -  Agrees to sign the Informed Consent

               -  Willingness to remove tattoo

               -  Willingness to have photographs and color measurements of the treated area taken
                  and to be used for marketing and educational presentation and/or publications

               -  Willingness to follow the treatment schedule and post treatment care requirement
                  for tattooing and removal

               -  Not planning to remove the tattoo in a different procedure during the time of the
                  experiment

        Exclusion Criteria:

          1. Skin conditions

               -  Skin type 5 and 6

               -  History of keloid formation

               -  Active herpes simplex

               -  Psoriasis or vitiligo

          2. Other medical conditions

               -  HIV or Hepatitis

               -  Pregnancy or intention to become pregnant in the next 6 months

               -  No allergic reaction during the tattooing process.

          3. Medication

               -  Currently taking anticoagulant medication, blood thinners, steroids or
                  immunosuppressive

               -  Taking isotretinoin (Accutane) currently or within the last 6 months

               -  Minocyclin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David J Friedman, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Friedman Skin &amp; Laser Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lilach Gavish, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Friedman Skin &amp; Laser Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr David Friedman Laser &amp; Skin Center, Diskin 60 st.</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2012</study_first_submitted>
  <study_first_submitted_qc>January 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2012</study_first_posted>
  <results_first_submitted>November 9, 2012</results_first_submitted>
  <results_first_submitted_qc>November 22, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 21, 2012</results_first_posted>
  <last_update_submitted>November 22, 2012</last_update_submitted>
  <last_update_submitted_qc>November 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tattoo removal</keyword>
  <keyword>ultrasound</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment period: 20-Nov-2011 to 11-Mar-12 Location: Dermatological clinic</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Treatment</title>
          <description>Cupola tattoo removal treatment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment</title>
          <description>Cupola tattoo removal treatment</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.1" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Israel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Tattoo Removal Efficiency</title>
        <description>Extent of Tattoo removal is quantified in 2 methods based on photographs taken at the baseline visit and at the termination visit:
Scoring by independent dermatologist
Measuring pigment clearance using image analysis</description>
        <time_frame>6 months (termination)</time_frame>
        <population>The number of participants that completed follow up.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>Cupola tattoo removal treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Tattoo Removal Efficiency</title>
          <description>Extent of Tattoo removal is quantified in 2 methods based on photographs taken at the baseline visit and at the termination visit:
Scoring by independent dermatologist
Measuring pigment clearance using image analysis</description>
          <population>The number of participants that completed follow up.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tolerability Score</title>
        <description>The tolerability of the procedure will be scored by the subject using a Pain Visual Analog Scale on a 0 to 10 scale where 10 represents the highest degree of pain and 0 represents a complete lack of pain.</description>
        <time_frame>0, 2, 4, 6, 8, 10 weeks (after every treatment)</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Treatment</title>
          <description>Cupola tattoo removal treatment</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Mild thickening of the skin</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David J. Friedman, Principal Investigator</name_or_title>
      <organization>Dr David Friedman Laser &amp; Skin Center</organization>
      <phone>+972-2-5635673</phone>
      <email>drfriedmanlaser@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

